Literature DB >> 28089250

Pathology of behavior in PD: What is known and what is not?

Kaylena A Ehgoetz Martens1, Simon J G Lewis2.   

Abstract

Abnormal behavior in Parkinson's disease (PD) stems from a complex orchestration of impaired neural networks that result from PD-related neurodegeneration across multiple levels. Typically, cellular and tissue abnormalities generate neurochemical changes and disrupt specific regions of the brain, in turn creating impaired neural circuits and dysfunctional global networks. The objective of this chapter is to provide an overview of the array of pathological changes that have been linked to different behavioral symptoms of PD such as depression, anxiety, apathy, fatigue, impulse control disorders, psychosis, sleep disorders and dementia.
Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anxiety; Apathy; Dementia; Depression; Fatigue; Hallucinations; Impulse control disorders; Neuropsychiatric; Parkinson's disease; Pathology; Psychosis; Sleep

Mesh:

Year:  2016        PMID: 28089250     DOI: 10.1016/j.jns.2016.12.062

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  9 in total

Review 1.  Assessment and Management of Neuropsychiatric Symptoms in Parkinson's Disease.

Authors:  Christoph Mueller; Anto P Rajkumar; Yi Min Wan; Latha Velayudhan; Dominic Ffytche; Kallol Ray Chaudhuri; Dag Aarsland
Journal:  CNS Drugs       Date:  2018-07       Impact factor: 5.749

Review 2.  Cognitive and behavioral disorders in Parkinson's disease: an update. II: behavioral disorders.

Authors:  Luigi Trojano; Costanza Papagno
Journal:  Neurol Sci       Date:  2017-10-16       Impact factor: 3.307

Review 3.  The Pathological Mechanism Between the Intestine and Brain in the Early Stage of Parkinson's Disease.

Authors:  Runing Yang; Ge Gao; Hui Yang
Journal:  Front Aging Neurosci       Date:  2022-06-24       Impact factor: 5.702

4.  Annual Prevalence of Use of Potentially Inappropriate Medications for Treatment of Affective Disorders in Parkinson's Disease.

Authors:  Danielle S Abraham; Thanh Phuong Pham Nguyen; Sean Hennessy; Shelly L Gray; Dawei Xie; Daniel Weintraub; Allison W Willis
Journal:  Am J Geriatr Psychiatry       Date:  2020-05-18       Impact factor: 4.105

Review 5.  Insights into the Pathophysiology of Psychiatric Symptoms in Central Nervous System Disorders: Implications for Early and Differential Diagnosis.

Authors:  Giulia Menculini; Elena Chipi; Federico Paolini Paoletti; Lorenzo Gaetani; Pasquale Nigro; Simone Simoni; Andrea Mancini; Nicola Tambasco; Massimiliano Di Filippo; Alfonso Tortorella; Lucilla Parnetti
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

6.  Alterations of the Motor and Olfactory Functions Related to Parkinson's Disease in Transgenic Mice With a VMAT2-Deficiency in Dopaminergic Neurons.

Authors:  Song Jiang; Stefan Berger; Yajuan Hu; Dusan Bartsch; Yanghua Tian
Journal:  Front Neurosci       Date:  2020-04-28       Impact factor: 4.677

7.  Sensory focused exercise improves anxiety in Parkinson's disease: A randomized controlled trial.

Authors:  Eric N Beck; Mary T Y Wang; Brittany N Intzandt; Quincy J Almeida; Kaylena A Ehgoetz Martens
Journal:  PLoS One       Date:  2020-04-16       Impact factor: 3.240

8.  Early Cognitive Impairment Behind Nigrostriatal Circuit Neurotoxicity: Are Astrocytes Involved?

Authors:  Macarena L Herrera; Romina Deza-Ponzio; Marisa S Ghersi; Emilce A de la Villarmois; Miriam B Virgolini; Mariela F Pérez; Victor A Molina; María J Bellini; Claudia B Hereñú
Journal:  ASN Neuro       Date:  2020 Jan-Dec       Impact factor: 4.146

9.  Effect of ALDH2 on Sleep Disturbances in Patients with Parkinson's Disease.

Authors:  Chia-Yen Lin; Rwei-Ling Yu; Ruey-Meei Wu; Chun-Hsiang Tan
Journal:  Sci Rep       Date:  2019-12-12       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.